An Open-label Extension Trial of Cannabidiol (GWP42003-P, CBD) for Focal Seizures in Tuberous Sclerosis Complex.
Conditions: Tuberous Sclerosis Complex; Seizures, FocalIntervention: Drug: GWP42003-PSponsor: GW Research LtdNot yet recruiting - verified September 2015
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Research | Tuberous Sclerosis